Description

Vivimed Labs Ltd. equity shares will be included under 'B' group effective December 26, 2025.

Summary

BSE has announced that equity shares of Vivimed Labs Ltd. (Scrip Code: 532660) will be reclassified and included under ‘B’ group effective December 26, 2025. This change in group classification will modify the trading parameters and characteristics applicable to the company’s shares.

Key Points

  • Vivimed Labs Ltd. (Scrip Code: 532660) will move to ‘B’ group
  • Change effective from December 26, 2025
  • Notice issued on December 18, 2025
  • Trading members have been notified of this reclassification
  • Contact person: Ms. Kinjal More (+91-7304278788) for clarifications

Regulatory Changes

The equity shares of Vivimed Labs Ltd. will be reclassified from their current group to ‘B’ group. This reclassification changes the trading characteristics and applicable rules for the security under BSE’s group classification framework.

Compliance Requirements

  • Trading members must update their systems to reflect the new group classification
  • Trading members should ensure compliance with all trading rules applicable to ‘B’ group securities
  • Any queries or clarifications should be directed to Ms. Kinjal More on +91-7304278788

Important Dates

  • Notice Date: December 18, 2025
  • Effective Date: December 26, 2025 - Vivimed Labs shares will trade under ‘B’ group from this date

Impact Assessment

Market Impact: Medium - The reclassification to ‘B’ group may affect trading volumes and investor participation as ‘B’ group securities typically have different trading parameters compared to other groups.

Operational Impact: Trading members need to update their systems and ensure their trading infrastructure is configured for ‘B’ group characteristics before the effective date.

Investor Impact: Investors trading in Vivimed Labs shares should be aware that group changes can affect margin requirements, settlement processes, and overall trading dynamics for the security.

Impact Justification

Group reclassification from current group to B group affects trading parameters and investor eligibility for Vivimed Labs shares